CasInvent Pharma develops new therapeutic options for the treatment of selected malignancies.
CasInvent has raised €1.3M across 1 funding round from 2 investors, most recently a round in Sep 2022. Based in Brno, Czech Republic; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-27 | Other | €1.3M |
| i&i Biotech Fund,KHAN Technology Transfer Fund I |
| View deal → |
